Watson-Marlow Reveals Plans for New Facility in Cork, Ireland

November 19, 2020
BioPharm International Editors

Watson-Marlow Limited Ireland has revealed plans for a new ISO 14644-1 Class 7 cleanroom to be added to the company’s existing site in Cork, Ireland.

Watson-Marlow Limited Ireland has revealed plans for a new facility in Cork, Ireland. The plans for a new ISO 14644-1 Class 7 cleanroom to be added to the company’s existing site in Cork were announced in a Nov. 16, 2020 press release.

The new facility will be certified to meet the regulatory demands of the pharmaceutical and biopharmaceutical manufacturing sector in Ireland. Once completed, the new facility will give customers of Watson-Marlow, based in Ireland, local access to essential bioprocess single-use assemblies for biopharmaceutical production.

In the press release, Denis Coll, biopharm sector manager—Ireland, said, “We’re delighted to build on our presence in Cork, reflecting the wealth of talent and opportunity available and the importance of Ireland in the growth of the global biopharmaceutical industry. Our puresu single-use assemblies harness Watson-Marlow’s extensive experience in biopharmaceutical processing, and the new facility will provide biotech and pharma manufacturing organizations in Ireland with specifically designed, validated products to support their innovation. The new ISO accredited facility offers a sustainable, Ireland-based supply chain that reflects Watson-Marlow’s commitment to engineering a sustainable future.”

Source: Watson-Marlow

Related Content:

News | Supplier News | Manufacturing